↓ Skip to main content

Heart Failure: From Research to Clinical Practice

Overview of attention for book
Cover of 'Heart Failure: From Research to Clinical Practice'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 99 The Evolution of mHealth Solutions for Heart Failure Management
  3. Altmetric Badge
    Chapter 105 Pathogenesis, Clinical Features and Treatment of Diabetic Cardiomyopathy
  4. Altmetric Badge
    Chapter 106 New Insights in Cardiac Calcium Handling and Excitation-Contraction Coupling
  5. Altmetric Badge
    Chapter 112 Combination of Hydralazine and Isosorbide-Dinitrate in the Treatment of Patients with Heart Failure with Reduced Ejection Fraction
  6. Altmetric Badge
    Chapter 115 Palliative Care in the Management of Patients with Advanced Heart Failure
  7. Altmetric Badge
    Chapter 120 The Role of Cardiologists in the Management of Patients with Heart Failure
  8. Altmetric Badge
    Chapter 126 Heart Failure and Kidney Disease
  9. Altmetric Badge
    Chapter 132 Dysthyroidism and Chronic Heart Failure: Pathophysiological Mechanisms and Therapeutic Approaches
  10. Altmetric Badge
    Chapter 135 Critical Appraisal of Multivariable Prognostic Scores in Heart Failure: Development, Validation and Clinical Utility
  11. Altmetric Badge
    Chapter 136 Management of Bradyarrhythmias in Heart Failure: A Tailored Approach
  12. Altmetric Badge
    Chapter 137 Optimizing Management of Heart Failure by Using Echo and Natriuretic Peptides in the Outpatient Unit
  13. Altmetric Badge
    Chapter 140 Circulating Biomarkers in Heart Failure
  14. Altmetric Badge
    Chapter 142 Percutaneous Mitral Valve Interventions and Heart Failure
  15. Altmetric Badge
    Chapter 143 Evolving Role of Natriuretic Peptides from Diagnostic Tool to Therapeutic Modality
  16. Altmetric Badge
    Chapter 144 Physical Training and Cardiac Rehabilitation in Heart Failure Patients
  17. Altmetric Badge
    Chapter 145 Left Ventricular Assist Devices – A State of the Art Review
  18. Altmetric Badge
    Chapter 146 Central Sleep Apnea with Cheyne-Stokes Breathing in Heart Failure – From Research to Clinical Practice and Beyond
  19. Altmetric Badge
    Chapter 149 Treatment of Heart Failure with Preserved Ejection Fraction
  20. Altmetric Badge
    Chapter 176 Athlete’s Heart and Left Heart Disease
  21. Altmetric Badge
    Chapter 178 Transition of Left Ventricular Ejection Fraction in Heart Failure
  22. Altmetric Badge
    Chapter 179 Combination Therapy of Renin Angiotensin System Inhibitors and β-Blockers in Patients with Heart Failure
  23. Altmetric Badge
    Chapter 181 Heart Failure: From Research to Clinical Practice
  24. Altmetric Badge
    Chapter 182 The Art and Science of Using Diuretics in the Treatment of Heart Failure in Diverse Clinical Settings
  25. Altmetric Badge
    Chapter 183 Advanced Non-invasive Imaging Techniques in Chronic Heart Failure and Cardiomyopathies
  26. Altmetric Badge
    Chapter 198 Erratum to: Management of Bradyarrhythmias in Heart Failure: A Tailored Approach
  27. Altmetric Badge
    Chapter 204 Erratum to: Percutaneous Mitral Valve Interventions and Heart Failure
Attention for Chapter 105: Pathogenesis, Clinical Features and Treatment of Diabetic Cardiomyopathy
Altmetric Badge

Readers on

mendeley
55 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Pathogenesis, Clinical Features and Treatment of Diabetic Cardiomyopathy
Chapter number 105
Book title
Heart Failure: From Research to Clinical Practice
Published in
Advances in experimental medicine and biology, January 2017
DOI 10.1007/5584_2017_105
Pubmed ID
Book ISBNs
978-3-31-978279-9, 978-3-31-978280-5
Authors

Núria Alonso, Pedro Moliner, Dídac Mauricio, Alonso, Núria, Moliner, Pedro, Mauricio, Dídac

Abstract

Patients with type 1 and type 2 diabetes mellitus (T1D and T2D) show an increased incidence of heart failure (HF) even after adjustment for well established risk factors for HF such as hypertension and ischaemic heart disease. The resulting specific form of cardiomyopathy is known as diabetic cardiomyopathy" (DCM). Pathogenetic mechanisms underlying DCM are likely to be multifactorial, from altered myocardial metabolism (hyperglycaemia, hyperinsulinaemia, increased circulating fatty acids and trglycerides) to microvascular disease, autonomic neuropathy, and altered myocardial structure with fibrosis. Current medical treatment recommendations from scientific societies on HF in patients with diabetes mellitus (DM) do not differ from those for patients without DM. Regarding the effect of different hypoglycaemic drugs on HF in patients with DM, and considering the best available current evidence, the sodium-glucose-co-transporter 2 inhibitors and metformin seem to be especially advantageous regarding the effects in patients with T2D and HF.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 55 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 20%
Student > Master 7 13%
Researcher 4 7%
Student > Ph. D. Student 3 5%
Other 3 5%
Other 4 7%
Unknown 23 42%
Readers by discipline Count As %
Medicine and Dentistry 17 31%
Nursing and Health Professions 2 4%
Neuroscience 2 4%
Social Sciences 2 4%
Agricultural and Biological Sciences 1 2%
Other 7 13%
Unknown 24 44%